GlassScriptPhysician profile
Michael J Cobb
NPI 1003813866
$3,187.96
in general payments reported to CMS, 2019-2025
38 companies · $1,290 in 2025
The $1,290 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,171 · 2022: $257 · 2023: $201 · 2024: $268 · 2025: $1,290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,759.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $836.67 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $290.27 | 2021-2022 | |
| Inspire Medical Systems, INC. | $249.81 | 2024-2025 | Inspire |
| Novo Nordisk INC | $233.24 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Teva Pharmaceuticals USA, INC. | $151.48 | 2021-2024 | Ajovy |
| Lundbeck LLC | $107.74 | 2024-2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $97.38 | 2021 | |
| Pfizer INC. | $96.74 | 2023-2025 | |
| Pacira Therapeutics, INC. | $86.19 | 2021 | |
| Exact Sciences Corporation | $72.49 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Redhill Biopharma INC. | $60.60 | 2021 | |
| Glaxosmithkline, LLC. | $59.37 | 2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $59.23 | 2024-2025 | Capvaxive, Gardasil 9, M-M-R II |
| Dexcom, INC. | $59.16 | 2024-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $54.79 | 2021 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $53.76 | 2021 | |
| Antares Pharma, INC. | $49.59 | 2025 | Xyosted |
| Scilex Pharmaceuticals INC. | $48.60 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $47.35 | 2025 | |
| Edwards Lifesciences Corporation | $45.63 | 2025 | |
| Electronic Waveform Lab, INC. | $40.23 | 2021-2022 | |
| Nevro Corp. | $30.63 | 2021 | |
| Horizon Therapeutics Plc | $30.51 | 2022 | |
| Stimwave Technologies Incorporated | $30.01 | 2021 | |
| Boston Scientific Corporation | $29.86 | 2021 | |
| Indivior INC. | $27.64 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $27.39 | 2021 | |
| Verona Pharma, INC. | $26.64 | 2025 | Ohtuvayre |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.84 | 2025 | Ofev |
| Tolmar, INC. | $24.44 | 2025 | Jatenzo |
| Abbott Laboratories | $21.46 | 2025 | Freestyle Libre 3 |
| Si-Bone, INC. | $21.06 | 2021 | |
| Biodelivery Sciences International, INC. | $18.40 | 2021 | |
| Ibsa Pharma INC. | $18.26 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.91 | 2021 | |
| Paratek Pharmaceuticals, INC. | $13.84 | 2025 | Nuzyra |
| Almatica Pharma LLC | $13.69 | 2021 | |
| Orexo US, INC. | $13.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cobb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.